MILWAUKEE, Wisconsin, Sept. 11 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its August 2023 edition (Vol. 11, Issue 8):

Basic tumor immunology:

* NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells